Meforal Xr

Metformin Hydrochloride, the active ingredient in Meforal Xr, is a biguanide presented as an oral tablet for Oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.\n\nGNH India supplies Meforal Xr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meforal Xr (metformin) is employed in the management of disorders related to impaired glucose metabolism.\n\n- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose to achieve glycaemic targets.\n- Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes.\n- Polycystic ovary syndrome (PCOS): improves insulin sensitivity and may help regulate menstrual cycles.

Metformin is generally well tolerated, but several adverse reactions have been reported.\n\nCommon Side Effects:\n- Gastrointestinal upset: nausea, abdominal discomfort, and diarrhoea.\n- Metallic taste: transient alteration in taste perception.\n- Weight loss: modest reduction in body weight.\n\nSerious or Rare Side Effects:\n- Lactic acidosis: rare but potentially fatal metabolic disturbance.\n- Vitamin B12 deficiency: may develop with long‑term therapy.\n- Hypersensitivity reactions: rash, urticaria, or angio‑edema.

Metformin should be used with awareness of specific safety considerations.\n\n- Renal function: assess creatinine clearance before initiation and periodically thereafter.\n- Hepatic impairment: avoid in patients with significant liver disease.\n- Cardiovascular status: monitor in patients with unstable heart failure.\n- Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare professional.\n- Concomitant alcohol: limit intake to reduce risk of lactic acidosis.\n- Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metformin may interact with other medicines, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Iodinated contrast agents: can precipitate acute renal failure, increasing lactic acidosis risk.\n- Cimetidine: may raise metformin plasma concentrations.\n\nModerate Interactions (Monitor Closely):\n- Diuretics (thiazides, loop): may affect renal clearance of metformin.\n- ACE inhibitors or ARBs: combined use can impact renal function.\n- Beta‑blockers: may mask hypoglycaemic symptoms when used with insulin.